Back to dashboard
All PlansCoverageHigh impact

March 2020 In The Know

EmblemHealth·NY·Provider News
Effective date
Mar 1, 2020
We identified it
Jun 20, 2026
Days to comply

Summary

EmblemHealth waives all cost-sharing (copayments, coinsurance, deductibles) for COVID-19 diagnostic visits, lab tests, and telehealth visits when using in-network providers. Preauthorization is not required for COVID-19 testing, and providers must not collect any payments from EmblemHealth members for these specific services.

Action Required

Action needed
Immediately: Billing team must stop collecting copayments, coinsurance, and deductibles from all EmblemHealth members for COVID-19 diagnostic visits, lab tests, and telehealth visits with in-network providers. Update billing system to waive cost-sharing for these services. Do not submit preauthorization requests for COVID-19 testing. Follow CDC guidelines for COVID-19 screening and coding. Normal cost-sharing applies for follow-up care and treatment including hospital admissions.